ArticleAsian journal of transfusion science
Optimizing platelet transfusion practices in hemato-oncology patients: A comprehensive analysis at a tertiary care oncology center.
Article in Asian journal of transfusion science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsPlatelet transfusions play a crucial role in managing thrombocytopenia in hemato-oncology patients. This study aimed to analyze platelet transfusion practices and evaluate the correlation between clinical and laboratory parameters before and after transfusion across different disease groups. In addition, assessed platelet increments in ABO-matched versus mismatched transfusions. MATERIALS AND
methodsA total of 1197 platelet transfusions were analyzed, applying stringent inclusion and exclusion criteria that excluded pediatric and elderly populations, surgical oncology patients, and cases with incomplete or missing data. The study revealed significant findings related to patient demographics, diagnosis distribution, ward-wise distribution, blood group analysis, and the impact of plasma reduction and storage duration on posttransfusion platelet increments.
resultsMale patients constituted the majority (72%), with the highest prevalence in the 41-60 years' age group. ABO-identical transfusions demonstrated significantly higher platelet increments compared to nonidentical transfusions and storage duration influenced posttransfusion platelet counts. These findings highlight the need for continuous monitoring and refinement of platelet transfusion strategies based on evolving clinical practices.
conclusionOptimizing platelet transfusion practices through evidence-based approaches and regular audit can improve the quality of transfusion services. Future prospective interventional studies with larger sample sizes are warranted to further refine the transfusion protocols and improve patient outcomes in hemato-oncology setup.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.